Symed Labs Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is RIVAROXABAN, with a corresponding US DMF Number 28807.
Remarkably, this DMF maintains an Active status since its submission on November 06, 2014, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 21, 2015, and payment made on December 11, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II